InsidersTradesSigma
Follow the Vicore Pharma Holding AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Vicore Pharma Holding AB has recorded 5 insider filings. Market capitalisation: €3.1bn. The latest transaction was disclosed on 8 July 2026 (Purchase). Among the most active insiders: Yasir Al-Wakeel. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€176,070
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Vicore Pharma Holding AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 31.40.
33Σ signal
Fundamental score
Ranked 22,474 of 29,064 companies
32.7
score / 100
Value13
Quality52
FCF yld-13%
Earn yld-16%
EV/EBITDA·
ROE-57%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 July 2026
Declarations5 total
363 shares@ €13.78990.0015% mcap100.0% of flowDepåbevisISIN US92581R1041FI:csv-bbd56d68340298b4cd4c
3 shares@ €13.900.0000% mcap100.0% of flowDepåbevisISIN US92581R1041FI:csv-5d0997c4ef5a13bdfb2e
670 shares@ €14.900.0031% mcap100.0% of flowDepåbevisISIN US92581R1041FI:csv-90937ac96d34791f19f3
160,220 shares@ SEK 10.56030.0051% mcap100.0% of flowAktieISIN SE0007577895FI:csv-0c7f17d1fd70b47c327b
10,000 shares@ €0.70370.0002% mcap100.0% of flowAktieISIN SE0007577895FI:A003O165-1
5 of 5 declarations
关于 Vicore Pharma Holding AB
Vicore Pharma Holding AB 是一家生物制药公司，专注于开发呼吸系统疾病的治疗方法。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。